Your Health, We Care

Home >Drug List>Revumenib>Indications of Revumenib

Revumenib(LuciRevu)

Release date: 2026-10-21 15:13:34     Recommended: 2

Indicated for adults and pediatric patients ≥1 year with relapsed/refractory KMT2A-translocated acute leukemia or NPM1-mutated AML without other suitable treatments.